Literature DB >> 22527876

A prospective cohort study on hospital mortality due to Clostridium difficile infection.

J M Wenisch1, D Schmid, G Tucek, H-W Kuo, F Allerberger, V Michl, P Tesik, H Laferl, C Wenisch.   

Abstract

PURPOSE: Although an increase in burden of disease has frequently been reported for Clostridium difficile infection (CDI), specific data on the effect of CDI on a patient's risk of death or overall hospital mortality are scarce. Therefore, we performed a prospective cohort study to analyse the effect of CDI on the risk of pre-discharge all-cause death in all inpatients with CDI compared to all inpatients without CDI during 2009 in a single hospital.
METHODS: Clostridium difficile infection was defined as by the European Society of Clinical Microbiology and Infectious Diseases. Data were collected from the medical charts of CDI patients and from the hospital discharge data of non-CDI and CDI patients. The effect measures of CDI used to compute the risk of pre-discharge all-cause death were risk ratio, attributable risk, mortality fraction (%) and population attributable risk percentage. Co-morbidity was categorized using the Charlson co-morbidity score in which a value of ≤2 was defined as low co-morbidity and that of >2 as moderate/severe co-morbidity. A stratified analysis and a Poisson regression model were applied to adjust for the effects of the risk factors sex, age and severity of co-morbidity.
RESULTS: A total of 185 hospitalized patients with CDI were compared to 38,644 other hospitalized patients without CDI admitted between 1 January 2009 and 31 December 2009. The mean age of the CDI and non-CDI patients was 74.3 (range 72.3-76.4) and 51.9 (range 51.6-52.1) years, respectively. Of the 185 CDI, 136 (73.5%) and 49 (26.5%) were categorized with low and high co-morbidity, respectively, versus 32,107 (83.4%) and 6,352 (16.5%), respectively, in non-CDI patients. Overall, 24 of the 185 CDI patients (13%) versus 1,021 of the 38,459 non-CDI patients (2.7%) died during their hospital stay, resulting in a relative risk of pre-discharge death of 4.89 [95% confidence interval (CI) 3.35-7.13] for CDI patients, a CDI attributable risk of death of 10.3 per 100 patients and a CDI attributable fraction of 79.5 % (95% CI 70.1-86 %). After adjustment for age, sex and co-morbidity the relative risk of pre-discharge death was 2.74 (95% CI 1.82-4.10; p < 0.0001) for patients with CDI, and the proportion of hospital deaths due to CDI was 1.72 (95% CI 1.22-2.05).
CONCLUSION: The results of this study lead to the conclusion that hospitalized patients with CDI are--independent of age, sex and co-morbidity severity--2.74-fold more likely to die during their hospital stay than all other hospitalized patients. The eradication of CDI in the hospital could have prevented 1.72% of in-hospital deaths in our study population during the 1 year of the study.

Entities:  

Mesh:

Year:  2012        PMID: 22527876     DOI: 10.1007/s15010-012-0258-1

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  33 in total

1.  Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec.

Authors:  Jacques Pépin; Louis Valiquette; Benoit Cossette
Journal:  CMAJ       Date:  2005-09-22       Impact factor: 8.262

2.  European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDI).

Authors:  M P Bauer; E J Kuijper; J T van Dissel
Journal:  Clin Microbiol Infect       Date:  2009-12       Impact factor: 8.067

3.  Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec.

Authors:  Jacques Pépin; Nathalie Saheb; Marie-Andrée Coulombe; Marie-Eve Alary; Marie-Pier Corriveau; Simon Authier; Michel Leblanc; Geneviève Rivard; Mathieu Bettez; Valérie Primeau; Martin Nguyen; Claude-Emilie Jacob; Luc Lanthier
Journal:  Clin Infect Dis       Date:  2005-09-20       Impact factor: 9.079

4.  Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada.

Authors:  Jacques Pepin; Marie-Eve Alary; Louis Valiquette; Evelyne Raiche; Joannie Ruel; Katalin Fulop; Dominique Godin; Claude Bourassa
Journal:  Clin Infect Dis       Date:  2005-04-25       Impact factor: 9.079

5.  Characterization of toxin A-negative, toxin B-positive Clostridium difficile isolates from outbreaks in different countries by amplified fragment length polymorphism and PCR ribotyping.

Authors:  Renate J van den Berg; Eric C J Claas; Duddy H Oyib; Corné H W Klaassen; Lenie Dijkshoorn; Jon S Brazier; Ed J Kuijper
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

6.  Fluoroquinolone use and risk factors for Clostridium difficile-associated disease within a Veterans Administration health care system.

Authors:  Lynne V McFarland; Jill E Clarridge; Henry W Beneda; Gregory J Raugi
Journal:  Clin Infect Dis       Date:  2007-09-26       Impact factor: 9.079

7.  Distribution of Clostridium difficile strains from a North American, European and Australian trial of treatment for C. difficile infections: 2005-2007.

Authors:  Adam K Cheknis; Susan P Sambol; David M Davidson; Kristin J Nagaro; Maria C Mancini; G Aida Hidalgo-Arroyo; Jon S Brazier; Stuart Johnson; Dale N Gerding
Journal:  Anaerobe       Date:  2009-09-06       Impact factor: 3.331

8.  Clean Care is Safer Care: a worldwide priority.

Authors:  Didier Pittet; Liam Donaldson
Journal:  Lancet       Date:  2005-10-08       Impact factor: 79.321

9.  Growth and geographic variation in hospitalizations with resistant infections, United States, 2000-2005.

Authors:  Marya D Zilberberg; Andrew F Shorr; Marin H Kollef
Journal:  Emerg Infect Dis       Date:  2008-11       Impact factor: 6.883

10.  Hospitalizations and deaths associated with Clostridium difficile infection, Finland, 1996-2004.

Authors:  Outi Lyytikäinen; Heli Turunen; Reijo Sund; Marja Rasinperä; Eija Könönen; Petri Ruutu; Ilmo Keskimäki
Journal:  Emerg Infect Dis       Date:  2009-05       Impact factor: 6.883

View more
  14 in total

Review 1.  [Coronary heart disease and its differential treatment].

Authors:  M Diewitz
Journal:  Med Welt       Date:  1975-10-24

Review 2.  Colonoscopic versus nasogastric fecal transplantation for the treatment of Clostridium difficile infection: a review and pooled analysis.

Authors:  R Postigo; J H Kim
Journal:  Infection       Date:  2012-07-31       Impact factor: 3.553

3.  Clostridium Difficile Associated Disease: Burden of and Predictors for in Hospital Fatal Outcome. Results of a Hospital-Based Study, Bucharest, Romania.

Authors:  Niculae Ion Nedelcu; Petre Iacob Calistru; Emanoil Ceausu
Journal:  Maedica (Buchar)       Date:  2015-06

4.  Association between Clostridium difficile infection and antimicrobial usage in a large group of English hospitals.

Authors:  Joao B Pereira; Tracey M Farragher; Mary P Tully; Jonathan Jonathan Cooke
Journal:  Br J Clin Pharmacol       Date:  2014-05       Impact factor: 4.335

5.  An agent-based simulation model for Clostridium difficile infection control.

Authors:  James Codella; Nasia Safdar; Rick Heffernan; Oguzhan Alagoz
Journal:  Med Decis Making       Date:  2014-08-11       Impact factor: 2.583

6.  Low vitamin D level is an independent predictor of poor outcomes in Clostridium difficile-associated diarrhea.

Authors:  Wallace J Wang; Sondra Gray; Cristina Sison; Sushma Arramraju; Bijo K John; Syed A Hussain; Sang H Kim; Preeti Mehta; Moshe Rubin
Journal:  Therap Adv Gastroenterol       Date:  2014-01       Impact factor: 4.409

Review 7.  Treatment of recurrent Clostridium difficile infection: a systematic review.

Authors:  J C O'Horo; K Jindai; B Kunzer; N Safdar
Journal:  Infection       Date:  2013-07-10       Impact factor: 3.553

8.  Severe Clostridium difficile infection: incidence and risk factors at a tertiary care university hospital in Vienna, Austria.

Authors:  Peter Starzengruber; Luigi Segagni Lusignani; Thomas Wrba; Dieter Mitteregger; Alexander Indra; Wolfgang Graninger; Elisabeth Presterl; Magda Diab-Elschahawi
Journal:  Wien Klin Wochenschr       Date:  2014-06-06       Impact factor: 1.704

9.  Decreasing Clostridium difficile infections by an antimicrobial stewardship program that reduces moxifloxacin use.

Authors:  Judith Maria Wenisch; Susanne Equiluz-Bruck; Marta Fudel; Ingun Reiter; Andrea Schmid; Erna Singer; Andreas Chott
Journal:  Antimicrob Agents Chemother       Date:  2014-06-16       Impact factor: 5.191

10.  Long-Term Clinical Outcome of Clostridium difficile Infection in Hospitalized Patients: A Single Center Study.

Authors:  Young Seok Doh; You Sun Kim; Hye Jin Jung; Young Il Park; Jin Won Mo; Hyun Sung; Kyung Jin Lee; Young Ki Seo; Jeong Seop Moon; Seong Woo Hong
Journal:  Intest Res       Date:  2014-10-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.